2026 NPPES data Rheumatology Physician NPI 1003162546 MD
Verify on CMS →

INDHIRA BISONO JIMENEZ, MD

Rheumatology Physician in TALLAHASSEE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
604
Medicare Part D claims · 182 beneficiaries · Rheumatology Physician avg: 2K
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.15/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$327.57
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

INDHIRA BISONO JIMENEZ, MD reported a CMS MIPS final score of 99.15/100 — above the 83.1 national average — and filed 604 Medicare Part D claims in 2023.

99.15/100
MIPS score · +16 vs avg
604
Part D claims, 2023
88%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

INDHIRA BISONO JIMENEZ, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

INDHIRA BISONO JIMENEZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about INDHIRA BISONO JIMENEZ, MD?

High performer (top quartile)

NPI registry status

Active

Issued 08/02/2012

NPI 1003162546

Primary specialty

Rheumatology Physician

Mid-sized

6,181 US NPIs in this specialty

Medicare Part D claims

604 71% vs specialty avg

2023 prescription claims

Specialty avg: 2,054

MIPS final score

99.15/100 16.05000000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Rheumatology Physician compares to other specialties among Florida providers

Florida providers

Rheumatology Physician share within Florida

1. Rheumatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Rheumatology Physician share within Florida

Medicare quality performance — MIPS

INDHIRA BISONO JIMENEZ, MD's 2023 MIPS final score plotted against the Rheumatology Physician national average

High performer (top quartile)
MIPS Final Score
99.15/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Rheumatology Physician) — 99.15/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Rheumatology Physician) — 99.15/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

INDHIRA BISONO JIMENEZ, MD appears in the CMS NPPES registry as a Rheumatology Physician provider holding MD credentials at 3900 ESPLANADE WAY, TALLAHASSEE, FL, 32311, with a listed phone of (850) 431-3867. NPI 1003162546 was issued on 08/02/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BISONO JIMENEZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 604 prescription claims written by this provider, covering 182 Medicare beneficiaries and totaling roughly $453K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.15/100 for the 2023 performance year, compared with the national average of 83.1.

Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3900 ESPLANADE WAY
TALLAHASSEE, FL 32311

Provider Details

NPI 1003162546
Specialty Rheumatology Physician
Credentials MD
Gender Female
NPI Issued 08/02/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.15
Final Score
Avg: 83.1
99
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where INDHIRA BISONO JIMENEZ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TALLAHASSEE MEMORIAL HEALTHCARE INC
TALLAHASSEE, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for INDHIRA BISONO JIMENEZ, MD. Source: openpaymentsdata.cms.gov.

Total received

$328

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to INDHIRA BISONO JIMENEZ, MD. To verify INDHIRA BISONO JIMENEZ, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

INDHIRA BISONO JIMENEZ, MD — brand share 12.0%
Specialty average (est.)

12% brand-name claims vs 88% generic, on 604 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

604
Total Claims
$453K
Total Drug Cost
182
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,124
Total Day Supply
31,467
Brand vs Generic
12% brand / 88% generic
Brand Drug Cost
$432K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
70.0 years
Avg HCC Risk Score
1.31
Gender Split
73% female / 27% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What INDHIRA BISONO JIMENEZ, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisone
208
Hydroxychloroquine Sulfate
95
Methotrexate
Methotrexate Sodium
49
Allopurinol
41
Folic Acid
23
Methotrexate Sodium
Methotrexate Sodium/Pf
23
Colchicine
22
Humira(Cf) Pen
Adalimumab
22
Meloxicam
14
Leflunomide
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Rheumatology Physician Overview

How INDHIRA BISONO JIMENEZ, MD fits within the Rheumatology Physician landscape nationally.

6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider

INDHIRA BISONO JIMENEZ, MD's 604 claims are below the specialty average of 2,054.

Nearby Rheumatology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as BISONO JIMENEZ.

Compare Rheumatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is INDHIRA BISONO JIMENEZ, MD's specialty?
INDHIRA BISONO JIMENEZ, MD specializes in Rheumatology Physician and practices in TALLAHASSEE, Florida. Credentials: MD.
How much does INDHIRA BISONO JIMENEZ, MD prescribe under Medicare Part D?
In 2023, INDHIRA BISONO JIMENEZ, MD wrote 604 Medicare Part D claims totaling $453K in drug costs for 182 beneficiaries.
What is INDHIRA BISONO JIMENEZ, MD's Medicare quality score?
INDHIRA BISONO JIMENEZ, MD has a CMS MIPS Final Score of 99.15/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is INDHIRA BISONO JIMENEZ, MD located?
INDHIRA BISONO JIMENEZ, MD is located at 3900 ESPLANADE WAY, TALLAHASSEE, FL, 32311. Phone: (850) 431-3867.
What is INDHIRA BISONO JIMENEZ, MD's NPI number?
INDHIRA BISONO JIMENEZ, MD's National Provider Identifier (NPI) is 1003162546, issued on 08/02/2012.
Does INDHIRA BISONO JIMENEZ, MD prescribe more brand-name or generic drugs?
INDHIRA BISONO JIMENEZ, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $432K in brand drug costs.
How many Rheumatology Physician providers are there in the US?
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does INDHIRA BISONO JIMENEZ, MD prescribe most often?
Based on 2023 Medicare Part D data, INDHIRA BISONO JIMENEZ, MD's most frequently prescribed drugs include Prednisone, Hydroxychloroquine Sulfate, Methotrexate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does INDHIRA BISONO JIMENEZ, MD accept Medicare?
INDHIRA BISONO JIMENEZ, MD appears in CMS Medicare data with 604 Part D claims and 182 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify INDHIRA BISONO JIMENEZ, MD's credentials?
INDHIRA BISONO JIMENEZ, MD's NPI is 1003162546 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology